These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10746677)

  • 1. Microvasculature and VEGF expression in cartilaginous tumors.
    Ayala G; Liu C; Nicosia R; Horowitz S; Lackman R
    Hum Pathol; 2000 Mar; 31(3):341-6. PubMed ID: 10746677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors.
    Kalinski T; Sel S; Kouznetsova I; Röpke M; Roessner A
    Pathol Res Pract; 2009; 205(5):339-45. PubMed ID: 19157720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular pattern in enchondroma and chondrosarcoma: clinical and immunohistologic study.
    Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
    Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):600-5. PubMed ID: 24897071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic cytokines in cartilage tumors.
    McGough RL; Lin C; Meitner P; Aswad BI; Terek RM
    Clin Orthop Relat Res; 2002 Apr; (397):62-9. PubMed ID: 11953596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors.
    Kouvaras E; Christoni Z; Siasios I; Malizos K; Koukoulis GK; Ioannou M
    Biotech Histochem; 2019 May; 94(4):283-289. PubMed ID: 30605014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors- clinical and histological correlation.
    Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
    Clinics (Sao Paulo); 2011; 66(9):1591-6. PubMed ID: 22179165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
    Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
    Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenesis in cartilage tumors].
    Kalinski T; Roessner A
    Pathologe; 2010 Oct; 31 Suppl 2():177-82. PubMed ID: 20661574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
    Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
    J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
    Wang H; Chen G; Zhang B
    Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation.
    Shibata M; Suzuki H; Nakatani M; Koba S; Geshi E; Katagiri T; Takeyama Y
    Histochem Cell Biol; 2001 Dec; 116(6):471-81. PubMed ID: 11810189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic study of neovascularization and VEGF expression in superficial esophageal carcinoma.
    Fujii T; Sudo T; Sueyoshi S; Tanaka T; Fujita H; Shirouzu K; Ban S; Toyonaga A; Kato S; Yamana H
    Int J Oncol; 2002 Dec; 21(6):1181-7. PubMed ID: 12429966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
    Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
    Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in VEGF expression and in the vasculature during the growth of early-stage ethylnitrosourea-induced malignant astrocytomas in rats.
    Yoshimura F; Kaidoh T; Inokuchi T; Shigemori M
    Virchows Arch; 1998 Nov; 433(5):457-63. PubMed ID: 9849861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer.
    Baillie R; Carlile J; Pendleton N; Schor AM
    J Clin Pathol; 2001 Feb; 54(2):116-20. PubMed ID: 11215279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.
    Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E
    Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic neovascularization in cartilage tumors.
    McGough RL; Aswad BI; Terek RM
    Clin Orthop Relat Res; 2002 Apr; (397):76-82. PubMed ID: 11953598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
    Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D
    J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.